Assessment | Screening | T0 Baseline | During intervention | T1 Post-intervention (14 weeks after T0) | T2 Follow-up (26 weeks after T0) | T3 Follow-up (52 weeks after T0) |
---|---|---|---|---|---|---|
GAD-7 | X | X | – | X | X | X |
PHQ-9 | X | X | – | X | X | X |
PHQ-4 (GAD-2 + PHQ-2) | – | – | X | – | – | |
M.I.N.I.-Plus | X | – | – | X | – | X |
SDS | X | – | – | X | – | X |
CERQ | – | X | – | X | X | X |
AAQ-II | – | X | – | X | X | X |
MHC-SF | – | X | – | X | X | X |
FFMQ-SF | – | X | – | X | X | X |
EQ-5D-5 L | – | X | – | X | X | X |
TIC-P | – | X | – | – | X | X |
CSQ-8 | – | – | – | X | – | – |
Self-esteem,Mastery andSupport | – | X | – | – | – | – |
Life events | – | X | – | – | – | – |
Somatic problems | – | X | – | – | – | – |
Demographics and other information | – | X | – | – | – | – |
Treatment credibility and expectancy | – | – | X | – | – | – |
Emotion regulation | – | X | X | X | X | X |
Behavioral avoidance | – | X | X | X | X | X |
Treatment expectancy | – | – | X | – | – | – |
Self-efficacy | – | – | X | – | – | – |
SRS | – | – | X | – | – | – |